"Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women"
NCT ID: NCT04384887
Last Updated: 2020-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2020-04-25
2020-08-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
(Beck depression scale contains 10 questions and a total of 1 to 100 points is obtained. High score indicates that depression and anxiety are high.) 0-16 points = mild depressive symptoms
17-29 points = moderate depressive symptoms
30-63 points = severe depressive symptoms
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women
NCT04629638
Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic
NCT04377412
Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic
NCT04558749
Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19)
NCT04595123
Stress in Pregnancy During the Covid19 Pandemic and Impact on the Newborn Neurodevelopment
NCT06362486
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
covid-19 positive pregnant women
It is planned to receive pregnant women who are admitted to the clinic or outpatient clinic and who are offered inpatient follow-up and treatment with the diagnosis of COVID-19.
Pregnant women who do not have covid-19 disease as a control group and who do not have a comorbid disease at similar gestational week will be included in the study. As a control group, covid-19 pcr negative patients will be admitted to our clinic in the same period.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no psychiatric diagnosis no use of psychiatric medicine
Exclusion Criteria
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ayşegül Bestel
UNKNOWN
İbrahim Polat
UNKNOWN
Merve Aldıkaçtıoğlu Talmaç
UNKNOWN
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pınar Yalcin bahat
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
beckcovid
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.